PROFFERED PAPERS Monday, March 19   —  1:00 PM   —  CC 217-219 Click on the blue numbers in parentheses to display abstracts. Click the button next to any title to add to Itinerary Planner... Section H - Endocrine Pathology Chaired by: Vania Nose and Zubair Baloch Time Title and Authors Itinerary Planner 1:00 Folate Receptor Expression in Human Parathyroids: A Novel Finding with Imaging and Therapeutic Implications (612) S Muller, RK Halkar, FK Villinger, K Im, SA Safley, J Sharma, CJ Weber - Emory University, Atlanta, GA Add 1:15 Somatostatin Receptor Subtype 2A Immunohistochemistry Using a New Monoclonal Antibody Selects Tumors Suitable for In Vivo Somatostatin Receptor Targeting (606) M Korner, B Waser, A Schonbrunn, A Perren, JC Reubi - Institute of Pathology of the University of Berne, Berne, Switzerland; Health Science Center Houston, University of Texas, Houston, TX Add 1:30 Prognostic Implications of Papillary Thyroid Carcinoma with Tall Cell Features (593) I Ganly, T Ibrahimpasic, M Rivera, I Nixon, F Palmer, SG Patel, A Shaha, RM Tuttle, JP Shah, R Ghossein - Memorial Sloan-Kettering Cancer Center, New York, NY Add 1:45 Effect of Subspecialty Sign-Out on the Diagnosis of Follicular- Patterned Thyroid Neoplasms (588) DJ Chute, TM Elsheikh, AP Hoschar - Cleveland Clinic, Cleveland, OH Add 2:00 Colorectal Poorly Differentiated Neuroendocrine Carcinomas (NECs) and Mixed Adenoneuroendocrine Carcinomas (MANECs): Insights into the Diagnostic Immunophenotype and Search for Prognostic Markers (609) S La Rosa, A Marando, C Capella - Ospedale di Circolo, Varese, Italy; University of Insubria, Varese, Italy Add 2:15 The Increase in Papillary Thyroid Cancer Incidence in the U.S. during the Last Four Decades Is Accompanied by a High and Stable Frequency of BRAF Mutations and a Sharp Increase in NRAS Mutations (602) CK Jung, JH Lubin, AV Brenner, MP Little, AJ Sigurdson, YE Nikiforov - University of Pittsburgh, Pittsburgh; The Catholic University of Korea, Seoul, Republic of Korea; National Institute of Health, Bethesda Add 2:30 Ribonucleotide Reductase Large Subunit (RRM1) Gene Epression Predicts Efficacy of Adjuvant Mitotane in Adrenocortical Cancer (625) M Volante, M Terzolo, M Fassnacht, I Rapa, A Germano, S Sbiera, F Daffara, P Sperone, GV Scagliotti, B Allolio, M Papotti, A Berruti - University of Turin, Orbassano, Turin, Italy; University Hospital Wurzburg, Wurzburg, Germany Add 2:45 Papillary Thyroid Carcinoma with Hobnail Features: Histopathological Criteria To Predict Aggressive Behavior (580) S Asioli, LA Erickson, A Righi, RV Lloyd - Department of Biomedical Sciences and Human Oncology, University of Turin, Turin, Italy; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; University of Wisconsin School of Medicine and Public Health, Madison, WI Add 3:00 RECESS, EXHIBITS, POSTER SESSION II   4:30 NATHAN KAUFMAN TIMELY TOPICS LECTURE Bogdan Czerniak, MD, PhD The Cancer Genome: A Step Towards Personalized Therapy CC Ballroom A-D Add